TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05816382: A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions

Sponsor: Takeda · Phase: PHASE2/PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 500 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$9,680,456

Rescue Site Savings

+$6,399,632

Unlock Full NCT05816382 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05816382 Rescue Dossier →